A conference focused on improving drug development processes.
Official title: C-Path Global Impact Conference
Funded at Critical Path Institute · NIH-11075617 · Data updated 2026-11-12
The C-Path Global Impact Conference is a friendly gathering where people from different areas, like medicine and patient advocacy, come together to share new ideas and solutions to make developing safe and effective medicines faster and better, especially for tough health issues like neurological disorders, rare diseases, and kids' health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Critical Path Institute NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $150,000 |
| NIH project number | 1R13FD008427-01 |
| Project ID | NIH-11075617 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with conditions in neurology, rare diseases, or pediatric populations may benefit from the advancements discussed at this conference.
✕Less likely to help
Patients with conditions not addressed by the conference's focus on drug development may not receive direct benefits.
What this research studies
The C-Path Global Impact Conference is a four-day event aimed at showcasing innovative solutions to enhance the efficiency and safety of medical product development. It brings together various stakeholders, including regulatory agencies, pharmaceutical companies, and patient groups, to foster collaboration and dialogue. Attendees will discuss advancements in developing novel therapeutics for challenging conditions, particularly in neurology, rare diseases, and pediatric populations. This conference serves as a platform for sharing knowledge and strategies to optimize drug evaluation processes.
Why it matters
Potential benefit: If successful, this conference could lead to improved drug development processes, resulting in safer and more effective treatments for patients.
How similar studies have gone: Previous conferences and collaborations in drug development have shown success in fostering innovation and improving treatment pathways.
Where this research is happening
-
Critical Path Institute
Tucson, United States Active
Researchers
- Principal investigator: Romero, Klaus — Critical Path Institute
- Study coordinator: Romero, Klaus
Related research
Other NIH-funded projects on the same topics.
-
Public-private collaboration to speed safer, better medicines
A powerful public-private partnership aims to accelerate medical innovation by sharing data and expertise to create regulatory-ready tools for drug development.
-
A clearer symptom questionnaire for chronic heart failure
This project checks whether a new questionnaire clearly captures symptoms experienced by people living with chronic heart failure.
-
Short virtual-reality test of everyday thinking and daily tasks for early Alzheimer's
This project develops a short virtual-reality test to measure everyday thinking and daily tasks in people with early, biomarker-positive Alzheimer's disease.
-
Evaluating a new scale to measure symptoms of chronic heart failure.
This study is working on a new tool to help understand the symptoms of chronic heart failure, like breathlessness and fatigue, and it’s looking for patients to share their experiences so we can make sure it’s really helpful for improving treatment.
-
Creating a tool to assess daily functioning in people with Alzheimer's disease using virtual reality
This study is testing a new virtual reality tool that helps understand how Alzheimer's affects daily activities, so we can better support people with the condition and improve treatments.
-
Creating a new tool to measure physical function in people with multiple sclerosis
This study is working on a new tool to help people with multiple sclerosis share how their physical abilities are affected by the condition, so that doctors and researchers can better understand the impact of treatments on their daily lives.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.